Light Mode
$34.60 ↑ +0.00 (+0.00%) Trading Up from the previous close of $34.60, $0.53 below the day’s high of $35.14
+11.45 (+49.46%) / 6M
Momentum, market sentiment, and recent alerts
CSLLY reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -50.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
